Alzheimer’s Drug Poses a Dilemma for the F.D.A.

If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say there isn’t enough evidence it works.

from NYT > Top Stories https://ift.tt/2SWS5su Read about Implantation bleeding quiz https://urlzs.com/fZw6K Chlamydia in men https://urlzs.com/W3NV1 https://ift.tt/2KrY6cn https://youtu.be/QFwQ6JvyPa8